The Zambia cholera vaccines market primarily comprises oral vaccines (WC-rBS and Shanchol) that are administered to individuals aged 1 year and above to protect against infection from Vibrio cholerae O1 and O139. Oral cholera vaccines play a key role in reducing the disease burden during outbreaks, when water and sanitation interventions are difficult to implement effectively in the short term.
The Global Zambia cholera vaccines market is estimated to be valued at US$ 1.47 MN in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Zambia cholera vaccines are Biovac Inc., Valneva SE., EMERGENT, Astellas Pharma Inc, Sanofi, EUBIOLOGICS CO., LTD, Johnson & Johnson Services Inc., Celldex Therapeutics. The rising incidence of cholera disease cases and increasing awareness for cholera vaccines among people are expected to offer lucrative opportunities in the market. Technological advancements involving improved oral cholera vaccines with single dose administration and long lasting immunity are estimated to boost the market growth.
Market drivers
The increasing government focus on cholera immunization programs as part of routine vaccination drives to control outbreaks is a major factor driving the growth of Zambia Cholera Vaccines Market Size. According to WHO, the government of Zambia introduced cholera vaccination in 2014 as an additional control measure during outbreaks. Along with, rising global healthcare expenditure to prevent spread of cholera infection and high disease prevalence during rainy seasons due to contamination of water are further estimated to propel the demand for cholera vaccines over the forecast period.
Challenges in Zambia Cholera Vaccines Market
The Zambia cholera vaccines market faces several challenges. The disease burden of cholera is highly dependent on factors such as availability of clean drinking water, sanitation and hygiene. Achieving universal access to basic sanitation and clean water remains a challenge for the country. Lack of infrastructure in remote and rural areas make these regions more vulnerable to cholera outbreaks. Poor implementation of vaccination programs and limited community awareness about the disease also impact the market’s growth. Zambia has one of the lowest doctor to patient ratios globally which affects diagnosis and treatment of cholera cases. Shortage of trained healthcare workers in the country pose operational challenges. Furthermore, limited availability of oral cholera vaccines and budgets constraints of government make mass vaccination programs difficult to rollout nationally.
SWOT Analysis
Strength: The market has strong growth potential driven by rising cholera cases in the country and increasing government focus on prevention through vaccination programs.
Weakness: Low diagnosis rates and lack of effective surveillance limits accurate disease monitoring. Budgetary constraints of government healthcare limits vaccination scale up.
Opportunity: Growing private sector investments and partnerships with NGOs provide scope to strengthen immunization infrastructure. Rising health awareness in communities offers scope for education programs.
Threats: Outbreaks are difficult to control due to lack of access to clean water in many regions. Political instability or conflicts can disrupt vaccination programs. Dependence on import of vaccines increases vulnerability to supply issues.
Zambia’s Southern and Lusaka provinces account for nearly 2/3rd of the total cholera disease burden in the country. These highly populated regions have seen recurrent outbreaks due to issues around water supply, drainage systems and sanitation. The Western province has emerged as the fastest growing market for cholera vaccines in recent years supported by increasing government spending on immunization programs in the province. Eastern and Northern regions also report sizable number of cases annually owing to proximity with neighboring countries like Tanzania and DR Congo which sees frequent cross border spread. However, in terms of prevention and vaccination rates, these regions lag behind Southern and Lusaka provinces.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author – Alice Mutum
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice’s dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights. LinkedIn